Should a non-contrast computed tomography (CT) scan of the head be performed before administering recombinant tissue plasminogen activator (rTPA) to a patient presenting with symptoms of acute ischemic stroke?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 27, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Yes, you must obtain a CT scan before administering rTPA

A non-contrast CT head is absolutely essential and must be performed before giving rTPA to exclude intracranial hemorrhage, which is an absolute contraindication to thrombolytic therapy. 1, 2

Why CT is Mandatory Before rTPA

The American Heart Association and American College of Radiology both provide Class I, Level A recommendations that either non-contrast CT (NECT) or MRI must be obtained before administering intravenous tPA to exclude intracranial hemorrhage (ICH). 1 This is non-negotiable because:

  • Hemorrhage exclusion is absolute: ICH is an absolute contraindication to thrombolytic therapy, and administering tPA in the presence of hemorrhage would be catastrophic. 1, 2

  • Early ischemic changes guide treatment: The CT also identifies early ischemic changes that help estimate irreversible tissue damage using scoring systems like ASPECTS, which is essential for therapeutic decision-making. 1

  • Stroke mimics must be excluded: Non-contrast CT rules out other etiologies (tumors, subdural hematomas, etc.) that may present with stroke-like symptoms but require completely different management. 1, 2

The Critical Caveat: Don't Let Imaging Delay Treatment

While imaging is mandatory, the acquisition of CT cannot unduly delay tPA administration within the 3-hour window. 1 This means:

  • Keep it simple initially: Within the first 3 hours, obtain non-contrast CT head rapidly. Additional studies like CTA or perfusion imaging are justifiable but cannot delay tPA bolus. 1

  • Time targets matter: In clinical practice, the average time from CT completion to tPA administration should be under 60 minutes, with door-to-needle times ideally under 60 minutes total. 3

  • Advanced imaging is optional early: MRI with diffusion-weighted imaging (DWI) is superior to CT for detecting acute ischemia, but only use it if it doesn't delay tPA administration. 1

What About Additional Vascular Imaging?

For patients within 3 hours presenting with suspected large vessel occlusion (LVO), you should obtain CTA head immediately after non-contrast CT if it doesn't delay tPA. 1 Here's the algorithm:

  • Start with non-contrast CT in all suspected stroke patients to exclude hemorrhage. 1, 2

  • Add CTA head immediately if clinical presentation suggests LVO (high NIHSS, cortical signs) because this identifies candidates for endovascular thrombectomy. 1

  • CTA neck can be added simultaneously to assess extracranial vasculature and aid surgical planning for thrombectomy. 1

  • CT perfusion is usually unnecessary within the first 6 hours and may actually be harmful by creating delays in clear thrombectomy candidates. 1

Special Considerations for Extended Time Windows

For patients presenting 6-24 hours after symptom onset with confirmed LVO on CTA, CT perfusion or MR perfusion may be required to determine thrombectomy eligibility. 1 This reflects the paradigm shift from time-based to tissue-based selection in extended windows. 1

Common Pitfalls to Avoid

  • Never give tPA without imaging first: Even if the clinical presentation is classic for stroke, hemorrhage must be excluded. 1

  • Don't order contrast-enhanced CT alone: There is no role for CT head with IV contrast in acute stroke evaluation—it provides no benefit and may obscure hemorrhage. 1, 2

  • Don't let perfusion imaging delay treatment: In the early window (<6 hours) with clear LVO, perfusion studies create harmful delays. 1

  • Frank hypodensity >1/3 MCA territory is a strong contraindication: While early ischemic changes don't preclude treatment, large completed infarcts on CT are a contraindication. 1

  • **Microbleeds on gradient-echo MRI (<5) are not contraindications**: If you happen to get MRI first, small numbers of microbleeds don't preclude tPA, though the risk with >5 microbleeds is uncertain. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

CT Imaging in Acute Stroke Evaluation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.